-
April 18: The Week in Cancer News
Gaps in goals-of-care discussions may harm young adults with cancer, and 1 in 6 participants in phase II trials get treatments that are eventually approved by the FDA.
by Marci A. Landsmann
-
April 11: The Week in Cancer News
NIH layoffs delay research benefiting cancer patients, and celebrity cancer news is often missing important information.
by Kevin McLaughlin
-
April 4: The Week in Cancer News
Some early-stage breast cancer patients may not need surgery, and FDA approves Imfinzi for muscle-invasive bladder cancer.
by Eric Fitzsimmons
-
March 28: The Week in Cancer News
New prostate cancer surgery approach can prevent sexual side effects, and some people with esophageal cancer may be able to avoid surgery.
by Thomas Celona
-
March 21: The Week in Cancer News
Cooling and compression help manage common side effect of chemotherapy, and deadlines encourage people to complete colorectal cancer screening.
by Marci A. Landsmann
-
March 14: The Week in Cancer News
Pickleball encourages more activity in cancer survivors, and urine test detects aggressive prostate cancer.
by Kevin McLaughlin
-
March 7: The Week in Cancer News
HPV vaccine credited for 80% drop in lesions that can lead to cervical cancer, and FDA approves targeted therapy for esophageal cancer.
by Thomas Celona
-
February 28: The Week in Cancer News
Exercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.
by Eric Fitzsimmons
-
February 21: The Week in Cancer News
Men with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.
by Marci A. Landsmann
-
February 14: The Week in Cancer News
Pesticide firms try to block cancer-related lawsuits, and cancer pain leads to greater tobacco and cannabis use.
by Kevin McLaughlin
Cancer Talk
Biotin Supplements Can Skew Cancer Lab Results
Products containing biotin can alter lab tests for people during and after cancer treatment.
by Laura Gesualdi Gilmore
Connecting More Patients to Cancer Clinical TrialsAACR conference brings experts together to discuss strategies to reach people historically left out of cancer research.
by Eric Fitzsimmons
Treatment Combination Improves Survival in EGFR-positive Lung CancerAdding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
